ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RGN Repligen Corp Dl 01

111.70
0.00 (0.00%)
11:31:12 - Realtime Data
Share Name Share Symbol Market Type
Repligen Corp Dl 01 TG:RGN Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 111.70 110.35 112.50 0.00 11:31:12

American Stock Exchange Lists Common Stock of RegeneRx Biopharmaceuticals, Inc.

28/03/2005 5:46pm

PR Newswire (US)


Repligen Corp Dl 01 (TG:RGN)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Repligen Corp Dl 01 Charts.
American Stock Exchange Lists Common Stock of RegeneRx Biopharmaceuticals, Inc. NEW YORK, March 28 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today listed the common stock of RegeneRx Biopharmaceuticals, Inc. under the ticker symbol RGN. RegeneRx's primary business focus is the commercialization of its proprietary product, Thymosin Beta 4 ("T Beta 4"), a 43 amino acid peptide and principal component of the company's technology platform. The company is concentrating its efforts on developing T Beta 4 for various therapeutic uses such as the treatment of injured tissue and organs and to accelerate the healing of chronic wounds caused by disease, abrasion, or other pathology. To date, the Food and Drug Administration has cleared the company for three Phase II dermal wound healing clinical trials. "We are very pleased to welcome RegeneRx Biopharmaceuticals to the American Stock Exchange," said John McGonegal, senior vice president of the Amex Equities Group. "In listing at the Amex, we will be able to offer RegeneRx the value-added services that a growing company needs to succeed in today's competitive market." The specialist in RegeneRx Biopharmaceuticals will be Cohen Specialists. For further information on RGN and other Amex-listed companies, please visit http://www.amex.com/. The American Stock Exchange(R) (Amex(R)) is the only primary exchange that offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 155 ETFs to date. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, please visit http://www.amex.com/. DATASOURCE: American Stock Exchange CONTACT: Mary Chung, American Stock Exchange, +1-212-306-1641, Web site: http://www.amex.com/

Copyright

1 Year Repligen Corp Dl 01 Chart

1 Year Repligen Corp Dl 01 Chart

1 Month Repligen Corp Dl 01 Chart

1 Month Repligen Corp Dl 01 Chart

Your Recent History

Delayed Upgrade Clock